FLUOROURACIL EBEWE VIAL 50MG/ML 10ML

Fluorouracil Ebewe 50mg/ml 10ml vial is a powerful anticancer medication designed for intravenous administration, playing a critical role in various chemotherapy regimens. As recognized by leading pharmaceutical e-commerce platforms like Nahdi Online, , and , this product is a vital component in the fight against numerous solid tumors.

Benefits of Use

• Effective in treating a wide range of solid tumors, including colorectal, breast, stomach, pancreatic, and head and neck cancers.
• A key component in established chemotherapy protocols, often used in combination with other anticancer agents.
• Aids in controlling disease progression, reducing tumor size, and improving overall patient outcomes.
• Helps to extend life expectancy and improve quality of life for patients undergoing cancer treatment.

How to Use

Fluorouracil Ebewe must be administered by a qualified healthcare professional experienced in oncology treatment.

1. This medication is administered via intravenous (IV) infusion, typically in a hospital or clinic setting.
2. The exact dosage, duration of treatment, and administration schedule are highly individualized. They depend on the specific type and stage of cancer, the patient's body surface area, overall health, and response to treatment.
3. Before administration, the vial contents may need to be diluted with an appropriate sterile solution as directed by the prescribing physician or pharmacist.
4. Regular monitoring of blood cell counts, liver function, and kidney function is essential throughout the treatment period to manage potential side effects and adjust dosage if necessary.

Caution & Warnings

• Healthcare Professional Supervision: Fluorouracil Ebewe should only be administered under the direct supervision of a physician qualified and experienced in the use of anticancer chemotherapeutic agents.
• Bone Marrow Suppression: May cause severe and potentially life-threatening bone marrow suppression (myelosuppression), leading to neutropenia (low white blood cells), thrombocytopenia (low platelets), and anemia. Patients will require regular blood count monitoring.
• Gastrointestinal Toxicity: Significant gastrointestinal side effects such as severe diarrhea, mucositis (inflammation of mucous membranes), nausea, and vomiting can occur. Immediate medical attention is required for severe symptoms.
• Cardiotoxicity: Potential for cardiovascular adverse effects, including angina, myocardial infarction, and arrhythmias, particularly in patients with pre-existing heart conditions.
• Neurological Effects & Hand-Foot Syndrome: May cause neurological toxicities and Hand-Foot Syndrome (palmar-plantar erythrodysesthesia), characterized by redness, swelling, and pain in the hands and feet.
• Pregnancy and Breastfeeding: Contraindicated during pregnancy due to high risk of fetal harm. Women of childbearing potential should use effective contraception. Breastfeeding is not recommended during treatment and for a specified period after.
• Drug Interactions: Caution is advised when co-administering with other medications, especially leucovorin, cimetidine, metronidazole, and warfarin, due to potential for altered efficacy or increased toxicity.
• Liver and Kidney Impairment: Dose adjustments may be necessary in patients with impaired liver or kidney function.
• Hypersensitivity: Rarely, severe hypersensitivity reactions can occur.

Ingredients

• Active Ingredient: Fluorouracil (50 mg/mL)
• Excipients: Typically include Sodium Hydroxide (for pH adjustment) and Water for Injection. Specific excipients may vary slightly by formulation.

Product Details

• Strength: 50 mg/mL
• Volume: 10 mL per vial
• Dosage Form: Solution for injection
• Manufacturer: EBEWE Pharma GmbH
• Drug Type: Prescription-only medication (POM)
• Storage: Store below 25°C. Protect from light. Do not refrigerate, as precipitation may occur.
• Packaging: Single-use glass vial